Perlegen Out-Licenses Patented Technologies for Genetic Diagnostics
Posted on: Wednesday, 16 July 2008, 09:01 CDT
Perlegen Sciences has opened its portfolio of patented technologies that together enable whole genome association studies capable of assessing an individual's predisposition to specific disease risks and treatment outcomes.
The family of six complementary patents covers methods of genetic analysis used to detect markers for multifactorial traits.
According to the company, these methods range from identification of tightly linked haplotype blocks and multi-loci markers to optimal matching of patient cases and controls, as well as methods for managing the massive data sets that accompany these analyses.
Bryan Walser, CEO of Perlegen, said: "The ability to determine which genetic markers are present in an individual across several areas of the genome and combine them in order to help quantify risk of developing or showing a specific multifactorial trait - will be central to the field of genetic diagnostics going forward."
Source: Datamonitor
Related Articles
- Wellcome Trust Case Control Consortium and Affymetrix Expand World's Largest Study of Genetic Diseases
- Genetic Association Information Network Selects Affymetrix SNP Array 6.0 for Latest Series of Studies
- Scientists Complete Map of Human Genetic Variation
- Prediction of Individual Clinical Outcome in MCI By Means of Genetic Assessment and ^Sup 18^F-FDG PET
- Genetic mapping to give thoroughbreds winning edge
- Genetic Epidemiology of Familial Amyloid Polyneuropathy in the Balearic Islands (Spain)
- Genotype-Phenotype Correlations (II): Assessing the Influence of Sequence Variants on the Clinical Phenotype in Multifactorial Disorders
- Linkage Analysis of Diabetes Status Among Hypertensive Families: The Hypertension Genetic Epidemiology Network Study
- Genetic Relationships and Admixture Among Sheep Breeds From Northern Spain Assessed Using Microsatellites1
- Genetic Diversity Among Alternaria Solani Isolates From Potatoes in South Africa
User Comments (0)

RSS Feeds